Avricore Health Inc.
AVCR.V
TSX
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -173.28% | -109.75% | -940.00% | -940.00% | -143.12% |
| Total Depreciation and Amortization | -57.72% | -61.72% | -62.99% | -62.99% | -66.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.53% | -84.91% | 7,633.33% | 7,633.33% | 231.54% |
| Change in Net Operating Assets | -17.67% | 24.80% | 22.44% | 22.44% | 63.74% |
| Cash from Operations | -111.97% | -225.55% | -3,738.27% | -3,738.27% | -49.24% |
| Capital Expenditure | 95.71% | 76.92% | 94.40% | 94.40% | 17.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -185.71% | 54.69% | 54.69% | -92.86% |
| Cash from Investing | 96.52% | 73.25% | 85.81% | 85.81% | 8.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 150.00% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.79% | -242.39% | -1,340.38% | -1,340.38% | -58.04% |